The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Progression patterns by types of metastatic spread, prostate-specific antigen (PSA), and clinical symptoms: Post-hoc analyses of ARAMIS.

Alicia K.  Morgans

Honoraria - Advanced Accelerator Applications; Astellas Pharma; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Clovis Oncology; Exelixis; Genentech; Janssen; Janssen; Janssen Oncology; Merck; Myovant Sciences; Pfizer; Sanofi

Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Exelixis; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Myovant Sciences; Myriad Genetics; Novartis; Sanofi

Research Funding - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Dendreon; Genentech; Myovant Sciences; Sanofi; Seattle Genetics/Astellas

Travel, Accommodations, Expenses - Sanofi

Christopher  Sweeney

Stock and Other Ownership Interests  - Leuchemix

Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Genentech/Roche; Janssen Biotech; Lilly; Pfizer; Sanofi

Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon; Janssen Biotech (Inst); Pfizer (Inst); Sanofi (Inst)

Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination

Christopher J.D.  Wallis

Honoraria - EMD Serono; Haymarket Medical Education; Knight Therapeutics; Tolmar

Consulting or Advisory Role - Janssen Oncology; Precision Point Specialty; Sesen Bio

Susan  Halabi

Employment - ASCO

Honoraria - Sanofi

Andrew J.  Armstrong

Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Exelixis; FORMA Therapeutics; GoodRx; Janssen; Merck; Myovant Sciences; Novartis; Pfizer

Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); FORMA Therapeutics (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)

Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)

Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc

Frank  Verholen

Employment - Bayer

Travel, Accommodations, Expenses - Bayer

Jorge A.  Ortiz

Employment - Bayer

Anja  Schmall

Employment - Bayer

Shankar  Srinivasan

Employment - Bayer

Marc-Oliver  Grimm

Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck Serono; MSD; Pfizer

Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD; Pfizer; Roche Pharma AG; Takeda

Research Funding - Bristol-Myers Squibb (Inst); Intuitive Surgical (Inst)

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono